Opinicus Capital Inc. Makes New $1.30 Million Investment in AbbVie Inc. (NYSE:ABBV)

Opinicus Capital Inc. purchased a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 8,363 shares of the company’s stock, valued at approximately $1,296,000. AbbVie makes up approximately 1.3% of Opinicus Capital Inc.’s portfolio, […]

Related Keywords

Raymond James ,Richarda Gonzalez ,Venclexta Venclyxto ,Azita Saleki Gerhardt ,William Blair ,Barclays ,Horrell Capital Management Inc ,Naples Money Management ,Abbvie Inc ,Abbvie Company Profile ,Blue Bell Private Wealth Management ,Securities Exchange Commission ,Bourgeon Capital Management ,Opinicus Capital Inc ,Core Wealth Advisors Inc ,Opinicus Capital ,Free Report ,Bell Private Wealth Management ,Capital Management ,Wealth Advisors ,Get Free Report ,Vie Inc ,Visit Holdingschannel ,Abbvie Daily ,Abbvie ,Nyse Abbv ,Abbv ,Medical ,00287y10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,